SBIR-STTR Award

Development of a Wearable Bladder Monitoring System
Award last edited on: 8/9/2019

Sponsored Program
SBIR
Awarding Agency
DOD : DHA
Total Award Amount
$1,149,912
Award Phase
2
Solicitation Topic Code
DHA172-012
Principal Investigator
Michael D Barton

Company Information

Creare LLC (AKA: Creare Inc~Creare Product Development LLC)

16 Great Hollow Road
Hanover, NH 03755
   (603) 640-2436
   info@creare.com
   www.creare.com
Location: Single
Congr. District: 02
County: Grafton

Phase I

Contract Number: W81XWH-18-C-0062
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2018
Phase I Amount
$149,989
Soldiers with spinal cord injury (SCI) face a lifetime of bladder dysfunction.Although the type and character of this dysfunction depends on the severity and level of spinal injury, many of these soldiers and veterans suffer from renal insufficiency, frequent and severe antibiotic-resistant bladder infections, and the emotional and social stress of unexpected bladder leakage.We propose that significant reductions in infections and other morbidities are possible by simply replacing scheduled voiding with a noninvasive wearable device that can monitor bladder volume and alert the patient to void.Our approach leverages an array of Creare-developed technologies and off the shelf products to form an integrated system.In Phase I, we will develop a preliminary design for a prototype wearable bladder measurement system.In Phase II, we will develop a prototype system and will evaluate its effectiveness.In Phase III, we will validate the technology through clinical trials and will use that data to obtain FDA clearance.

Phase II

Contract Number: W81XWH19C0013
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
2019
Phase II Amount
$999,923
Soldiers with spinal cord injury (SCI) face a lifetime of bladder dysfunction. Although the type and character of this dysfunction depends on the severity and level of spinal injury, many of these soldiers and veterans suffer from renal insufficiency, frequent and severe antibiotic-resistant bladder infections, and the emotional and social stress of unexpected bladder leakage. We propose that significant reductions in infections and other morbidities are possible by simply replacing scheduled voiding with a noninvasive wearable device that can monitor bladder volume and alert the patient to void.Our approach leverages an array of Creare-developed technologies and off the shelf products to form an integrated system. In Phase I, we demonstrated feasibility and developed a preliminary design for a prototype wearable bladder measurement system.In Phase II, we will develop a prototype system and will evaluate its effectiveness.In Phase III, we will validate the technology through clinical trials and will use that data to obtain FDA clearance.